Fanxi Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fanxi Xu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chaodong Wang
Department of Neurology & Neurobiology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China
1 shared publication - Hong Lai
Department of Neurology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China
1 shared publication - Junge Zhu
Department of Neurology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China
1 shared publication - Xian Li
Department of Neurology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China
1 shared publication - Xianlin Wang
Department of Neurology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China
1 shared publication - Xu-Ying Li
Department of Neurology and Neurobiology Xuanwu Hospital of Capital Medical University Beijing China
1 shared publication
Latest Publications
- Open Access
- 3 November 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (11) , 1546
Applications of Machine Learning to Diagnosis of Parkinson’s Disease
Background: Accurate diagnosis of Parkinson’s disease (PD) is challenging due to its diverse manifestations. Machine learning (ML) algorithms can improve diagnostic precision, but their generalizability across medical centers in China is underexplored. Objective: To assess the accuracy of an ML algorithm for PD diagnosis, trained and tested on data from different medical centers in China. Methods: A total of 1656 participants were included, with 1028 from Beijing (training set) and 628 from Fuzhou (external validation set). Models were trained using the least absolute shrinkage and selection operator–logistic regression (LASSO-LR), decision tree (DT), random forest (RF), eXtreme gradient boosting (XGboost), support vector machine (SVM), and k-nearest neighbor (KNN) techniques. Hyperparameters were optimized using five-fold cross-validation and grid search techniques. Model performance was evaluated using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve, accuracy, sensitivity (recall), specificity, precision, and F1 score. Variable importance was assessed for all models. Results: SVM demonstrated the best differentiation between healthy controls (HCs) and PD patients (AUC: 0.928, 95% CI: 0.908–0.947; accuracy: 0.844, 95% CI: 0.814–0.871; sensitivity: 0.826, 95% CI: 0.786–0.866; specificity: 0.861, 95% CI: 0.820–0.898; precision: 0.849, 95% CI: 0.807–0.891; F1 score: 0.837, 95% CI: 0.803–0.868) in the validation set. Constipation, olfactory decline, and daytime somnolence significantly influenced predictability. Conclusion: We identified multiple pivotal variables and SVM as a precise and clinician-friendly ML algorithm for prediction of PD in Chinese patients.
- 3 November 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (11) , 1546
Open AccessApplications of Machine Learning to Diagnosis of Parkinson’s Disease
Background: Accurate diagnosis of Parkinson’s disease (PD) is challenging due to its diverse manifestations. Machine learning (ML) algorithms can improve diagnostic precision, but their generalizability across medical centers in China is underexplored. Objective: To assess the accuracy of an ML algorithm for PD diagnosis, trained and tested on data from different medical centers in China. Methods: A total of 1656 participants were included, with 1028 from Beijing (training set) and 628 from Fuzhou (external validation set). Models were trained using the least absolute shrinkage and selection operator–logistic regression (LASSO-LR), decision tree (DT), random forest (RF), eXtreme gradient boosting (XGboost), support vector machine (SVM), and k-nearest neighbor (KNN) techniques. Hyperparameters were optimized using five-fold cross-validation and grid search techniques. Model performance was evaluated using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve, accuracy, sensitivity (recall), specificity, precision, and F1 score. Variable importance was assessed for all models. Results: SVM demonstrated the best differentiation between healthy controls (HCs) and PD patients (AUC: 0.928, 95% CI: 0.908–0.947; accuracy: 0.844, 95% CI: 0.814–0.871; sensitivity: 0.826, 95% CI: 0.786–0.866; specificity: 0.861, 95% CI: 0.820–0.898; precision: 0.849, 95% CI: 0.807–0.891; F1 score: 0.837, 95% CI: 0.803–0.868) in the validation set. Constipation, olfactory decline, and daytime somnolence significantly influenced predictability. Conclusion: We identified multiple pivotal variables and SVM as a precise and clinician-friendly ML algorithm for prediction of PD in Chinese patients.